New life for antidiabetic drugs

Riekelt H. Houtkooper and Johan Auwerx
Additional contact information
Riekelt H. Houtkooper: Riekelt H. Houtkooper and Johan Auwerx are in the Laboratory for Integrative and Systems Physiology, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. admin.auwerx@epfl.ch
Johan Auwerx: Riekelt H. Houtkooper and Johan Auwerx are in the Laboratory for Integrative and Systems Physiology, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland. admin.auwerx@epfl.ch

Nature, 2010, vol. 466, issue 7305, 443-444

Abstract: Antidiabetic drugs that activate the protein PPARγ had a bright start but soon lost their appeal because of undesirable side effects. Subtle modifications may once again make them suitable for treating diabetes.

Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/466443a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:466:y:2010:i:7305:d:10.1038_466443a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/466443a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().